MDS-07-01 is an acrylate-carbonate ester impurity reference standard. The presence of a hydrolytically sensitive central carbonate group and a reactive terminal acrylate suggests that MDS-07-01 can arise as a process-related impurity during API synthesis or as a degradation product under specific storage conditions. Given its structural complexity, MDS-07-01 serves as a critical marker for monitoring the formation of high-molecular-weight impurities that may impact drug purity and safety. The availability of MDS-07-01 as a certified reference material enables analytical laboratories to validate HPLC methods capable of resolving and quantifying this specific impurity, supporting compliance with ICH guidelines for pharmaceutical development.
|
Parameter |
Specification |
|
Product Name |
MDS-07-01 |
|
CAS Number |
3027717-56-9 |
|
Molecular Formula |
C₁₈H₃₂O₅ |
|
Molecular Weight |
328.44 g/mol |
|
Purity (HPLC) |
≥95.0% |
|
Boiling Point |
401.8 ± 28.0 °C (Predicted, 760 Torr) |
|
Density |
0.982 ± 0.06 g/cm³ (Predicted, 25 °C) |
|
Storage Condition |
-20°C, sealed under inert atmosphere |
|
Advantage |
Detail |
|
Production Strength |
GMP-certified campus spanning 100+ mu, 3 multi-purpose workshops, 6 D-grade clean zone production lines, and 150+ reactors (20L–5000L), supporting high/low temp, anaerobic & hydrogenation; kg to ton scale production. |
|
Fast Delivery |
R&D samples: one week; commercial orders: 1–2 months after payment. Express (DHL/FedEx) or air/sea freight available. |
|
Global Partners |
Trusted by 30+ pharmaceutical companies in USA, Europe, India, Brazil, and Southeast Asia; long-term cooperation with generic drug manufacturers, CROs, and impurity standard distributors. |
|
Licensed Exporter |
Valid drug import/export license — no compliance delays. |
|
Dual Quality Grades |
Both research/pharma grade（≥98%）and high-purity impurity grade（≥99%）available to meet diverse customer needs. |
A: MDS-07-01 is primarily applied as a reference marker in the development, validation, and routine execution of HPLC and UPLC methods. It supports impurity profiling, forced degradation studies, and the preparation of regulatory submissions that require comprehensive related substance data.
A: No. MDS-07-01 is intended solely as an analytical reference standard for pharmaceutical quality control and method validation. It is not for human consumption, therapeutic administration, or any in vivo application.
Store MDS-07-01 at -20°C in a tightly sealed container, protected from light and moisture at all times. Allow the sealed package to equilibrate to ambient temperature before opening to prevent moisture condensation. The compound’s carbonate diester bridge and terminal acrylate group are susceptible to hydrolysis and polymerization; therefore, storage under an inert atmosphere (argon or nitrogen) is strongly recommended. Adherence to the storage recommendations specified in the Certificate of Analysis is essential for maintaining product integrity throughout its documented shelf life.
Ready to integrate MDS-07-01 into your analytical workflow? Contact Cosperpharm with the details below, and we’ll provide a prompt, no-obligation quotation.
Address
No. 2 Yangguang 3rd Road, Duodao Chemical Cycle Industrial Park, Jingmen City, Hubei Province, China
Tel
![N-[2-(Dodecyldisulfanyl)ethyl]acrylamide](/upload/8820/n-2-dodecyldisulfanyl-ethyl-acrylamide-913889.webp "N-[2-(Dodecyldisulfanyl)ethyl]acrylamide")
![Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester](/upload/8820/heptanoic-acid-7-4-hydroxybutyl-amino-1-hexylnonyl-ester-832597.webp "Heptanoic acid, 7-[(4-hydroxybutyl)amino]-, 1-hexylnonyl ester")
